[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"hip-arthritis\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:hip-arthritis":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,9,0,[8,44,68,100,121,144,168,191,222],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":43},"100481049","evaluating-xperience-advanced-surgical-irrigation-100481049",false,"NCT05543941","Evaluating XPERIENCE™ Advanced Surgical Irrigation","Evaluating XPERIENCE™ Advanced Surgical Irrigation on Risk of Periprosthetic Joint Infection: A Multicenter Randomized Controlled Trial","XPERIENCE","Inclusion Criteria:\n\n1. Male and female patients aged 18 years or older\n2. Diagnosis of osteoarthritis, inflammatory arthritis, osteonecrosis, or post-traumatic arthritis to the affected joint.\n3. Primary TKA, THA, and HR\n4. Subjects receiving both cemented or uncemented orthopaedic implants\n5. Willing and able to sign written consent, follow study protocol and attend follow-up\n\nExclusion Criteria:\n\n1. Inability or refusal to sign informed consent form\n2. Non-English or French speaking, and no licensed translator, family member or substitute decision maker available.\n3. Prior arthroplasty procedure to the affected joint\n4. Procedures involving solid HA implants\n5. Oncologic diagnosis to the affected joint.\n6. Non-TKA, THA or HR prosthesis (i.e., hemiarthroplasty, unicompartmental arthroplasty etc.)\n7. Allergy to any of the components of XP Advanced Surgical Irrigation\n8. Allergy to iodine\n9. Presence of concurrent active infection, primary immunodeficiency, history of uncontrolled HIV (CD4 count \\\u003C200 cells\u002FuL), treatment with immunomodulatory medications for malignancy or autoimmune disease (with exception to inflammatory arthritis), chronic glucocorticosteroid use (≥20 mg of prednisone daily for at least 1 month with another cause of immunosuppression), and solid organ and\u002For bone marrow transplantation.\n10. History of septic arthritis to the affected joint within two years of surgery(1).\n11. History of steroid injection to the affected joint within the three months preceding surgery.\n12. Simultaneous bilateral total joint arthroplasty","ALL","18 Years",{"count":20,"type":21},7600,"ESTIMATED","INTERVENTIONAL",[24],"NA","A prospective, multi-center, double-arm, parallel, interventional, randomized, controlled clinical trial to assess the rate of periprosthetic joint infection (PJI) in patients undergoing primary total knee arthroplasty (TKA), total hip arthroplasty (THA) or hip resurfacing (HR) with XPERIENCE™ (XP) Advanced Surgical Irrigation versus dilute Betadine (DB).",[27,28,29,30],"Hip Osteoarthritis","Hip Arthritis","Knee Osteoarthritis","Knee Arthritis","RECRUITING","2026-05-25",{"date":34,"type":35},"2026-05-28","ACTUAL",{"date":37,"type":35},"2023-04-01",{"date":39,"type":21},"2027-12-31",{"name":41,"class":42},"Ottawa Hospital Research Institute","OTHER",8,{"id":45,"slug":46,"hasResults":11,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":50,"eligibilityCriteria":51,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":52,"targetDuration":54,"studyType":55,"phases":4,"briefSummary":56,"conditions":57,"keywords":4,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":61,"completionDateStruct":63,"leadSponsor":65,"locationsCount":67},"100638345","retrospective-and-prospective-evaluation-of-hip-short-stem-performed-by-anterior-approach-100638345","NCT07600632","Retrospective and Prospective Evaluation of Hip Short Stem Performed by Anterior Approach","Clinical and Radiographic Evaluation of a Short Stem for Primary Hip Replacement Performed by Anterior Approach: A Retrospective and Prospective Study","AMISP","Inclusion Criteria:\n\n* Diagnosis of primary hip osteoarthritis or osteonecrosis\n* Minimally invasive direct anterior approach\n* Cementless femoral component\n* Minimum follow-up of 2 years\n* Patient willingness to participate in the study with written informed consent\n* Age over 18 years\n* Male or female patients\n\nExclusion Criteria:\n\n* Other diagnoses of secondary hip osteoarthritis\n* Non-anterior surgical approach\n* Cemented or other types of components\n* Patient unwillingness to participate in the study\n* Inadequate clinical and radiological documentation",{"count":53,"type":21},400,"5 Years","OBSERVATIONAL","This study aims to evaluate the clinical, radiographic, and perioperative outcomes of short femoral stems implanted during primary total hip arthroplasty performed through a minimally invasive direct anterior approach (DAA). Short femoral stems have been developed to preserve proximal femoral bone stock, potentially provide a more physiological load transfer, and facilitate implantation through less invasive surgical exposures, particularly in younger and more active patients.\n\nThe stem is a cementless hydroxyapatite-coated triple-tapered short stem, has been previously used because its design allows simplified femoral canal preparation and easier implant insertion during minimally invasive anterior approaches, where femoral exposure may be technically demanding. However, previous reports have shown conflicting results regarding implant survivorship and radiographic outcomes, including increased rates of radiolucent lines, pedestal formation, and stem subsidence, particularly among younger and more active patients.\n\nThe present study will investigate the technical and clinical implications of using short femoral stems through a minimally invasive anterior approach. Primary outcomes will include perioperative complication rates, wound characteristics, peri-incisional tissue condition, postoperative bleeding, and other surgery-related complications. Secondary outcomes will include postoperative pain, functional recovery, clinical outcome scores, implant survivorship, and serial radiographic findings at short- and mid-term follow-up.\n\nGiven the limited evidence currently available regarding the short- and mid-term performance of short femoral stems implanted through the direct anterior approach, this study aims to provide a comprehensive clinical and radiographic evaluation of these implants over time. Adverse events will be continuously monitored through scheduled clinical and radiographic assessments.",[28],"2026-05-18",{"date":60,"type":35},"2026-05-20",{"date":62,"type":35},"2025-09-12",{"date":64,"type":21},"2030-12",{"name":66,"class":42},"Istituto Ortopedico Rizzoli",1,{"id":69,"slug":70,"hasResults":11,"nctId":71,"briefTitle":72,"officialTitle":72,"acronym":4,"eligibilityCriteria":73,"healthyVolunteers":11,"sex":17,"minAge":74,"maxAge":75,"enrollmentInfo":76,"targetDuration":4,"studyType":22,"phases":78,"briefSummary":79,"conditions":80,"keywords":84,"overallStatus":90,"whyStopped":4,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":92,"startDateStruct":94,"completionDateStruct":96,"leadSponsor":98,"locationsCount":67},"100365525","psychosocial-interventions-for-young-adults-with-hip-pain-100365525","NCT04039386","Psychosocial Interventions for Young Adults With Hip Pain","Inclusion Criteria:\n\n* We will enroll young adults (15-39) presenting to one of several physical therapy and orthopedic practices in the state of Iowa for treatment of nonarthritic hip pain.\n* Chief complaint of hip pain or dysfunction, and a diagnosis of a nonarthritic hip condition including labral tear, femoroacetabular impingement (FAI), snapping hip, femoral anteversion or dysplasia.\n\nExclusion Criteria:\n\n* Exclusion criteria will include age \\\u003C15 or \\>40 years\n* Difficulty with written English\n* Treatment for alternative conditions such as trochanteric bursitis, hip dislocation, avascular necrosis or fracture.","15 Years","39 Years",{"count":77,"type":21},150,[24],"Psychosocial conditions are common in young adults with hip pain including depression, anxiety, pain catastrophizing, and narcotic use. The incidence of these conditions is not well defined. Interventions to optimize psychosocial conditions with non-surgical or surgical treatments has not been investigated. The goal of this project is to determine the incidence of psychosocial conditions in the young adult population with hip pain and determine if cognitive based therapy can improve clinical outcomes in these individuals.",[81,82,27,28,83],"Hip Dysplasia","Hip Pain Chronic","Psychosocial Problem",[85,86,87,88,89],"Hip Pain","Hip Instability","Hip Impingement","Cognitive Based Therapy","Psychosocial Conditions","NOT_YET_RECRUITING","2026-04-14",{"date":93,"type":35},"2026-04-15",{"date":95,"type":21},"2026-09-01",{"date":97,"type":21},"2028-08-01",{"name":99,"class":42},"Michael C Willey",{"id":101,"slug":102,"hasResults":11,"nctId":103,"briefTitle":104,"officialTitle":105,"acronym":4,"eligibilityCriteria":106,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":107,"targetDuration":4,"studyType":22,"phases":109,"briefSummary":110,"conditions":111,"keywords":4,"overallStatus":90,"whyStopped":4,"lastUpdateSubmitDate":112,"lastUpdatePostDateStruct":113,"startDateStruct":115,"completionDateStruct":117,"leadSponsor":119,"locationsCount":67},"100611219","alexis-retractor-in-total-hip-arthroplasty-100611219","NCT07237737","Alexis Retractor in Total Hip Arthroplasty","Wound Healing Outcomes With and Without the Alexis Wound Retractor in Direct Anterior Approach Total Hip Arthroplasty","Inclusion Criteria:\n\n* Patients undergoing primary unilateral longitudinal direct anterior approach total hip arthroplasty\n* Patients undergoing primary total hip arthroplasty\n\nExclusion Criteria:\n\n* Patients with history of prior open surgery on the affected hip\n* Patients with history of prior total hip arthroplasty on the contralateral hip\n* Patients with allergies or absolute contraindication to standardized drugs administered within the University of Miami protocol for total hip replacement",{"count":108,"type":21},202,[24],"To determine if there is a difference in wound healing and surgical site infection (SSI) rates using the Alexis wound retractor vs. not using it in longitudinal direct anterior approach total hip arthroplasty.",[27,28],"2026-02-03",{"date":114,"type":35},"2026-02-05",{"date":116,"type":21},"2026-12",{"date":118,"type":21},"2028-01",{"name":120,"class":42},"University of Miami",{"id":122,"slug":123,"hasResults":11,"nctId":124,"briefTitle":125,"officialTitle":126,"acronym":4,"eligibilityCriteria":127,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":128,"targetDuration":4,"studyType":22,"phases":130,"briefSummary":131,"conditions":132,"keywords":4,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":135,"lastUpdatePostDateStruct":136,"startDateStruct":138,"completionDateStruct":140,"leadSponsor":142,"locationsCount":67},"100547396","evaluating-the-efficacy-of-a-mobile-application-in-postoperative-rehabilitation-100547396","NCT06407427","Evaluating the Efficacy of a Mobile Application in Postoperative Rehabilitation","Using a Mobile Application for In-Bed Conditioning Exercises for Orthopedic Postoperative Patients","Inclusion Criteria:\n\n* Provision of signed and dated informed consent form\n* Stated willingness to comply with all study procedures and availability for the duration of the study\n* English reading\u002Fspeaking\n* Are status post low-energy hip fracture, total knee\u002Fhip arthroplasty, or single to multilevel spinal fusion without paralysis\n* Must be able bodied enough to participate in a mobile app tool for physical therapy\n* Agreement to adhere to Lifestyle Considerations (see section 5.3) throughout study duration\\]\n\nExclusion Criteria:\n\n* Severe cognitive impairment: Not alert and oriented to person, place, time, and reason for being the hospital; and unable to follow 2 step commands\n* Severe physical impairment:\n\n  * Neurologic paralysis\n  * Polytraumas with restrictions incompatible with anti-gravity exercises\n  * Knee immobilization, bed rest\n* Unstable medical conditions:\n\n  * On ventilatory support\n  * Utilizing high degrees of oxygen support (continuous BiPAP, high flow nasal cannula, nonrebreather mask, aerosol mask \\>3L\u002Fmin)\n  * Hemodynamic instability requiring pressor medication support (can include those on pressors for elevated mean arterial pressure goals (MAPs))\n  * Neurologically instable with strokes, hemorrhages, increased intracranial pressures\n* Open wounds or surgical incisions\n\n  * Tenuous closed wounds requiring immobilization or bending restrictions\n  * Open wounds that are either packed\u002Fdressed or dressed with a wound vacuum\n  * Surgical wounds that are draining fluid or purulence\n* Vulnerable populations\n\n  * Incarcerated individuals\n* Patients without access to a mobile phone with iOS capability",{"count":129,"type":21},100,[24],"This study aims to evaluate the effectiveness of a mobile application in improving postoperative rehabilitation outcomes among patients undergoing orthopedic surgery.",[133,28,29,134],"Spine Degeneration","Hip Fractures","2025-08-29",{"date":137,"type":35},"2025-09-02",{"date":139,"type":35},"2025-07-21",{"date":141,"type":21},"2026-07",{"name":143,"class":42},"Yale University",{"id":145,"slug":146,"hasResults":11,"nctId":147,"briefTitle":148,"officialTitle":149,"acronym":4,"eligibilityCriteria":150,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":151,"targetDuration":4,"studyType":55,"phases":4,"briefSummary":153,"conditions":154,"keywords":4,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":157,"lastUpdatePostDateStruct":158,"startDateStruct":160,"completionDateStruct":162,"leadSponsor":164,"locationsCount":167},"100364703","mdr---pmcf-study-for-taperloc-complete-stems-100364703","NCT04028687","MDR - PMCF Study for Taperloc Complete Stems","Post Market Clinical Follow up Study to Provide Safety, Performance and Clinical Benefits Data of the Taperloc Complete Stems","Inclusion Criteria:\n\n* Patient must be 18 years of age or older and skeletally mature\n* Patient must be willing and able to sign IRB approved informed consent\n* Patient must have undergone primary or revision hip arthroplasty with the -Taperloc Complete stem according to a cleared indication, which includes the following:\n* Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis\n* Rheumatoid arthritis\n* Correction of functional deformity\n* Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable by other techniques\n\nExclusion Criteria:\n\n* Off-label use\n* Infection\n* Sepsis\n* Osteomyelitis\n* Uncooperative patient or patient with neurologic disorders who are incapable of following directions\n* Osteoporosis\n* Metabolic disorders which may impair bone formation\n* Osteomalacia\n* Distant foci of infections which may spread to the implant site\n* Rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram\n* Vascular insufficiency, muscular atrophy, or neuromuscular disease\n* Patient is known to be pregnant or nursing\n* Patient is a prisoner\n* Patient is a known alcohol or drug abuser\n* Patient has a psychiatric illness or cognitive deficit that will not allow for proper informed consent",{"count":152,"type":21},820,"The objective of this consecutive series PMCF study is to collect data confirming safety, performance, and clinical benefits of the Taperloc Complete stems when used for primary or revision total hip arthroplasty (implants) at 1,3,5,7 and 10-year follow-up\\*. Since Taperloc Complete was introduced to the EU in 2010, all available retrospective data will be collected from each patient and a prospective aspect to the study will be necessary to reach the 10-year time point.",[28,155,134,156,82],"Hip Disease","Hip Injuries","2025-03-10",{"date":159,"type":35},"2025-03-11",{"date":161,"type":35},"2020-02-13",{"date":163,"type":21},"2032-02-12",{"name":165,"class":166},"Zimmer Biomet","INDUSTRY",3,{"id":169,"slug":170,"hasResults":11,"nctId":171,"briefTitle":172,"officialTitle":173,"acronym":4,"eligibilityCriteria":174,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":175,"targetDuration":4,"studyType":55,"phases":4,"briefSummary":177,"conditions":178,"keywords":179,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":182,"lastUpdatePostDateStruct":183,"startDateStruct":185,"completionDateStruct":187,"leadSponsor":189,"locationsCount":67},"100502637","qist-collaborative---arthroplasty-research-cohort-arc-study-100502637","NCT05824845","QIST Collaborative - Arthroplasty Research Cohort (ARC) Study","QIST Collaborative - Arthroplasty Research Cohort (ARC) Study - a Collaborative, Longitudinal Observational Cohort Study of Patients Undergoing Primary Hip and Knee Replacements in the United Kingdom","Inclusion Criteria:\n\nParticipants must meet all of the inclusion criteria:\n\n1. UK Resident\n2. Able to read and understand documentation and questionnaires in English language\n3. Undergoing elective primary hip or knee arthroplasty (THR, TKR or UKR)\n4. Age 18 years or over\n5. Provides the necessary consents relating to data collection and use of study data, data linkage, future research and invitation to involvement in future trials\n\nExclusion Criteria:\n\nProvided a participant meets all of the inclusion criteria, there are no exclusion criteria for the cohort study.",{"count":176,"type":21},5000,"The ARC Study is a national observational cohort study to investigate patient reported and clinical outcomes after hip and knee replacements. The study has the following objectives:\n\n1. To evaluate outcomes following hip and knee replacements.\n2. To determine risk factors for adverse outcomes in primary hip and knee replacements.\n3. To identify targets for future research and intervention in patients undergoing primary hip and knee replacements\n4. To provide a resource from which to identify potential participants for future clinical trials, and to use data collected in the ARC Study as comparison or control data for trial participants who have been randomised to receive one or more interventions.\n\nParticipants are recruited and consented online. Patients are invited to participate by collaborating surgical teams nationally in outpatient clinics at the time of being added to a waiting list, in addition to an advertising campaign to recruit patients. They are directed to an online portal where they will be able to review further information.\n\nConsent and data collection is completed electronically through patients entering data online. Baseline demographics and characteristics are recorded, including details of socio-demographics, lifestyle, health status and patient reported outcome measures (PROMs). Patients then undergo hip\u002Fknee replacement and postoperative rehabilitation according to the standard care and protocols of the hospital and the preferences of their treating surgeon.\n\nFollow-up data, including PROMs, is collected via online questionnaires up to two years following surgery. The study will ultimately also enable multiple trials to be embedded within the cohort study, using a 'Trials within Cohorts' (TwiCs) methodology.",[28,30],[180,181],"Hip Replacement","Knee Replacement","2024-11-14",{"date":184,"type":35},"2024-11-18",{"date":186,"type":35},"2023-07-13",{"date":188,"type":21},"2031-05",{"name":190,"class":42},"Northumbria Healthcare NHS Foundation Trust",{"id":192,"slug":193,"hasResults":11,"nctId":194,"briefTitle":195,"officialTitle":196,"acronym":4,"eligibilityCriteria":197,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":198,"enrollmentInfo":199,"targetDuration":4,"studyType":22,"phases":201,"briefSummary":202,"conditions":203,"keywords":4,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":214,"lastUpdatePostDateStruct":215,"startDateStruct":217,"completionDateStruct":219,"leadSponsor":220,"locationsCount":67},"100562489","clinical-evaluation-and-cost-effectiveness-analysis-of-3d-digital-surgery-in-traumatology-100562489","NCT06603831","Clinical Evaluation and Cost-effectiveness Analysis of 3D Digital Surgery in Traumatology","Randomized, Prospective and Multicenter Clinical Study for the Clinical Evaluation and Cost-effectiveness Analysis of 3D Digital Surgery in Traumatology and Orthopedic Surgery","Inclusion Criteria:\n\n\\- Patients that requires one of the following surgical procedures \u002F interventions: Radius osteotomy due to non-articular metaphyseal malunion Complex acetabular arthroplasty Thoracic-lumbar spine arthrodesis.\n\n-Patients that can understand the clinical study and that are able to read, understand and sign the consent form\n\nExclusion Criteria:\n\n* Patients that are not able to read, understand or sign the consent form.\n* Patients that can't or have no support to complete the clinical trial.\n* Patients with complex deformities or complications that would require mandatory personalized digital surgery treatment","80 Years",{"count":200,"type":21},180,[24],"Digital surgery, in combination with patient specific instrumentation (PSI) is being used more and more in traumatology due to its proven benefits and applications. Nowadays, medical case planning and an optimal preparation before surgery are still a challenge for surgeons. This lack of preparation is translated into longer surgical procedures, potential complications, unnecessary sterilization of materials and a high number of fluoroscopies. 2D techniques such as Magnetic Resonance Imaging (MRI), Computed Tomography (CT) and X-rays remain essential for medical planning, however, in many cases, a 3D visualization is needed to achieve better results, especially in complex cases.The use of personalized medical instruments such as surgical guides has proven to increase clinical accuracy, assuring a better correction of bone deformities, and allowing a more precise location of implants and screw positioning. Furthermore, the use of 3D-printed patient-specific prosthesis can lead to better clinical outcomes as they reduce the number of complications as well as they present a longer lifespan compared to conventional generic implants.Despite the potential of 3D technology in the medical field, there is still a lack of robust studies that compares clinical benefits between digital surgery and conventional 2D surgery, and its economic impact is still unknown. Thus, the investigators propose this randomized, prospective and multi-center clinical study to evaluate the use of 3D technology in traumatology. The aim of this project is to prove that digital surgery is a cost-effective methodology and therefore it should be adopted by the public health system as a gold standard procedure.",[204,27,28,205,206,207,208,209,210,211,212,213],"Radius; Deformity","Hip Arthropathy","Spine Injury","Radius; Anomaly","Vertebra; Degeneration","Vertebral Fracture","Hip Prosthesis Infection","Spinal Fusion","Spine Osteoarthritis","Spinal Deformity","2024-11-08",{"date":216,"type":35},"2024-11-12",{"date":218,"type":35},"2024-10-21",{"date":39,"type":21},{"name":221,"class":42},"Corporacion Parc Tauli",{"id":223,"slug":224,"hasResults":11,"nctId":225,"briefTitle":226,"officialTitle":226,"acronym":4,"eligibilityCriteria":227,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":228,"targetDuration":4,"studyType":55,"phases":4,"briefSummary":230,"conditions":231,"keywords":4,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":237,"lastUpdatePostDateStruct":238,"startDateStruct":240,"completionDateStruct":242,"leadSponsor":244,"locationsCount":5},"100456771","safety-and-performance-assessment-of-the-symbol-range-of-medical-devices-in-patients-underlying-total-hip-arthroplasty-100456771","NCT05227924","Safety and Performance Assessment of the SYMBOL Range of Medical Devices in Patients Underlying Total Hip Arthroplasty","Inclusion Criteria:\n\n* Patient age \\> 18 years at implantation.\n* Patient who will undergo, during the study's period of inclusion, a total hip arthroplasty (primary or revision) with at least one SYMBOL medical device (DEDIENNE Santé).\n* Patient informed of his\u002Fher participation and willing to participate in the study.\n* Patient able to read, write and understand French.\n\nExclusion Criteria:\n\n* Patient deprived of freedom, under guardianship\u002Fcuratorship or placed under judicial protection\n* Patient unable to follow study procedures.\n* Patient who has already been included in the study for a total hip arthroplasty (primary or revision) with at least one SYMBOL medical device.",{"count":229,"type":21},747,"The purpose of this post-market clinical follow up study is to assess the safety and effectiveness of the SYMBOL range of medical devices. The study will evaluate the outcome of Total Hip Arthroplasty using medical devices from SYMBOL range over a period of 10 years.",[232,233,28,234,235,236],"Degenerative Hip Joint Disease","Post-traumatic Osteoarthritis","Femoral Neck Fractures","Avascular Necrosis of the Femoral Head","Failure of Prosthetic Joint Implant","2024-08-26",{"date":239,"type":35},"2024-08-27",{"date":241,"type":35},"2021-09-21",{"date":243,"type":21},"2034-09",{"name":245,"class":166},"Dedienne Sante S.A.S."]